FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Rifampin Injection
Status: Currently in Shortage
»Date first posted: 02/17/2021
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (Reverified 04/16/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 600 mg (NDC 63323-351-20)	Available	Check wholesaler inventory

Mylan Institutional, a Viatris Company (Reverified 04/16/2024)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 600 mg/10 mL (NDC 67457-445-60)	Unavailable	On backorder. Next supply in Q2-24.	Delay in shipping of the drug

Sanofi-Aventis U.S. LLC (Reverified 04/08/2024)

Company Contact Information:
800-633-1610

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)	Available